AliquantumRx Inc. announces a phase III MII funding for a project entitled “Development of Cethromycin

AliquantumRx Inc. announces the filing of a provisional patent application No. 62/942,508 entitled “Salts and

AliquantumRx Inc. announces that it has attracted an initial capital investment of up to $500,000